A Proteomics Signature of NASH - Non-Invasive Assessment of Nonalcoholic Fatty Liver Disease
Offered By: Labroots via YouTube
Course Description
Overview
Explore the latest advancements in proteomics for diagnosing and monitoring nonalcoholic steatohepatitis (NASH) in this comprehensive webinar presented by Dr. Arun Sanyal. Delve into the global prevalence of nonalcoholic fatty liver disease (NAFLD) and the urgent need for non-invasive diagnostic tools. Learn about the development and validation of proteomics-based models for assessing key liver biopsy components and at-risk NASH. Discover how these innovative "liquid biopsy" techniques could revolutionize NAFLD assessment, potentially replacing invasive liver biopsies. Gain insights into ongoing clinical trials, disease progression, and effective strategies for managing NASH. Engage with cutting-edge research on serum protein profiling and its implications for diagnosis, prognosis, and monitoring of NAFLD and NASH.
Syllabus
Introduction
Liver Journey
Effective Strategies
Collaborative Project
Data Summary
Disease Progression
Pivence Trial
Flint Study
Clinical Trials
Summary
Live QA
Taught by
Labroots
Related Courses
El abordaje multidisciplinar de las demenciasUniversidad de Cantabria via MirÃadax Demystifying Targeted Cancer Treatments
Cancer Research UK via FutureLearn Diagnosis and prognosis biomarkers in global health
Institut Pasteur via France Université Numerique Extracellular Vesicles in Health and Disease
University of California, Irvine via Coursera Procalcitonin: PCT as a Biomarker for Antimicrobial Stewardship
The British Society for Antimicrobial Chemotherapy via FutureLearn